MiMedx Group News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

26.10.17	MiMedx Announces Record Results For Third Quarter Of 2017 And Raises Full Year Revenue Guidance (PR Newswire)
24.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
18.10.17	New Clinical Evidence And A Landmark VLU Study To Be Presented At SAWC Fall Meeting (PR Newswire)
17.10.17	MiMedx Warns Of Fake Emails (PR Newswire)
17.10.17	MiMedx Notified By FDA That It Can Proceed With Phase 2B Investigational New Drug Clinical Trial For Osteoarthritis Of The Knee (PR Newswire)
16.10.17	MiMedx Announces Release Date for 2017 Third Quarter Results (PR Newswire)
13.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
11.10.17	Multicenter Randomized Controlled VLU Clinical Study Published in the International Wound Journal Demonstrates Significantly Higher Healing Rates of MiMedx EpiFix® (PR Newswire)
11.10.17	CRY Opens Wallet, LLY's JUNIPER Flops, MDXG Catches Eyes, RNN Awaits DATA In Q4 (RTTNews)
10.10.17	MiMedx Adds New Materials To Its Website Exposing Misinformation Disseminated Through Short Seller Attacks (PR Newswire)
10.10.17	MiMedx Announces Third Quarter Revenues Of $84.6 Million Exceeds Guidance By More Than 5 Percent (PR Newswire)
10.10.17	CLVS Seeks New Use For Rubraca, TNDM Effects Reverse Stock Split, MDXG On Watch (RTTNews)
09.10.17	MiMedx Board of Directors Authorizes $10 Million Increase to the Company's Share Repurchase Program (PR Newswire)
06.10.17	MiMedx to Present at the Janney Osteoarthritis Pain Conference (PR Newswire)
04.10.17	Lifshitz & Miller LLP Announces Investigation of Foundation Medicine, Inc., Health Insurance Innovations, Inc., Juno Therapeutics, Inc., LendingClub Corporation, MiMedx Group, Inc., Ooma, Inc. (PR Newswire)
03.10.17	Dr. Gloria Matthews Joins MiMedx As Its Senior Vice President Of Research And Development (PR Newswire)
03.10.17	VICL Soars After-hours, DMTX Deems RARE Bid Superior, MDXG On Watch (RTTNews)
02.10.17	MiMedx Completes Divestiture Of Its Stability Biologics Subsidiary (PR Newswire)
29.09.17	MiMedx Publishes Document on its Website Exposing False and Misleading Information Distributed By Viceroy Research and Aurelius Value (PR Newswire)
22.09.17	Block & Leviton LLP Investigates MiMedx Group, Inc. (MDXG) Following Revelation Of SEC Investigation (PR Newswire)
21.09.17	MiMedx provides Information on Its Interaction With The SEC (PR Newswire)
20.09.17	MiMedx Responds To Deceptive Short Seller Reports (PR Newswire)
19.09.17	MiMedx To Host Shareholder Call On September 21, 2017 To Update Progress On Various Strategic Initiatives And Respond To Topics Requested By Shareholders (PR Newswire)
19.09.17	MiMedx Files With The FDA To Initiate The Company's Investigational New Drug Phase 2 Clinical Trial For Osteoarthritis Of The Knee (PR Newswire)
18.09.17	MiMedx Patent Infringement Lawsuit Updates (PR Newswire)
18.09.17	MiMedx to Present at Cantor Fitzgerald's Global Healthcare Conference (PR Newswire)
13.09.17	MiMedx Backs Q3 Revenue View Despite Hurricane Irma Impact (RTTNews)
13.09.17	MiMedx Reiterates Its Third Quarter Revenue Expectation To Exceed $80 Million Despite Hurricane Irma (PR Newswire)
12.09.17	MiMedx Recognized as Number 5 on Fortune Magazine's List of the 100 Fastest Growing Public Companies (PR Newswire)
07.09.17	MiMedx Reports Further Developments in its Civil Litigation Against Former Employees (PR Newswire)
07.09.17	MiMedx Notified By FDA That It Can Proceed With Phase 3 Investigational New Drug Clinical Trial For Achilles Tendonitis (PR Newswire)
06.09.17	MiMedx To Attend Morgan Stanley's 15th Annual Global Healthcare Conference (PR Newswire)
06.09.17	MDXG Revises Q3 Outlook, Two Down, One To Go For BLPH, TECH Opens Wallet (RTTNews)
05.09.17	MiMedx Announces Its Expectations For Third Quarter Revenue To Exceed $80 Million And Surpass Its Previous Revenue Guidance (PR Newswire)
05.09.17	Daily Technical Summary Reports on Medical Equipment Stocks -- Hologic, Wright Medical, MiMedx, and Stryker (PR Newswire)
31.08.17	MiMedx Reports MultiCenter randomized Controlled VLU Clinical Study Accepted for Publication in The International Wound Journal (PR Newswire)
29.08.17	Connecticut Based BullBag Corporation Rallies Its Multiple Locations and Disaster Division to Respond to Hurricane Harvey (PR Newswire)
18.08.17	MiMedx Signs Definitive Agreement to Divest Stability Biologics Subsidiary as Part of Company's Strategic Focus on Biopharma (PR Newswire)
17.08.17	MiMedx Provides Update on Litigation with Terminated Employees (PR Newswire)
09.08.17	MiMedx Hits Milestone of One Million Allografts Distributed (PR Newswire)
09.08.17	SHAREHOLDER ALERT: Purcell Julie & Lefkowitz LLP Is Investigating MiMedx Group, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors (PR Newswire)
07.08.17	AQB Reaps A Bounty, CLSN Ends Dual Listing, MNK Opens Wallet, OMER On Watch (RTTNews)
04.08.17	MiMedx Files With The FDA To Initiate Its Investigational New Drug Achilles Tendonitis Phase 3 Clinical Trial (PR Newswire)
03.08.17	FDA Panel Snubs JNJ, CHMP Seeks More Data From PBYI, TBPH On Watch, AGRX Slumps (RTTNews)
02.08.17	MiMedx Reports Exceptional Results in Phase 2B Clinical Trial on the Use of AmnioFix® Injectable in the Treatment of Plantar Fasciitis (PR Newswire)
02.08.17	MiMedx Initiates Phase 3 Plantar Fasciitis Clinical Trial (PR Newswire)
01.08.17	MiMedx To Present At The 37th Annual Canaccord\|Genuity Growth Conference (PR Newswire)
27.07.17	Eagle's Wings Clipped, FDA Panel Snubs IPCI, No Respite For CUR, MDXG On Watch (RTTNews)
27.07.17	MiMedx Announces Record Results For The Second Quarter Of 2017 And Raises Full Year Revenue Guidance (PR Newswire)
26.07.17	Breakfast Technical Briefing on Medical Equipment Stocks -- Abbott Labs, Boston Scientific, Medtronic, and MiMedx (PR Newswire)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

UBS Group	27.65	2.14 %	K V
Novartis	88.82	1.30 %	K V
Part Grp Hldg	1’233.00	1.23 %	K V
Kuehne+Nagel Int	207.50	1.22 %	K V
Lonza Grp	538.00	1.05 %	K V
Swisscom	503.00	0.40 %	K V
Sonova Hldg	296.60	0.34 %	K V
Swiss Life Hldg	697.40	0.11 %	K V
Zurich Insur Gr	539.60	0.11 %	K V
Holcim	87.40	0.02 %	K V

Nachrichten zu MiMedx Group Inc

Aktien Top/Flop

Meistgelesene Nachrichten